The potential of proton beam therapy in paediatric cancer

Acta Oncologica

Volumn 44, Issue 8, 2005, Pages 871-875

  Björk Eriksson, Thomas ^a   Glimelius, Bengt ^b,c  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BEAM THERAPY; BONE MARROW SUPPRESSION; CANCER INCIDENCE; CANCER RADIOTHERAPY; CHILDHOOD CANCER; HUMAN; MEDICAL DECISION MAKING; MEDULLOBLASTOMA; PRIORITY JOURNAL; PROTON RADIATION; RADIATION DOSE; REVIEW; TREATMENT PLANNING;

CHILD; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; MEDULLOBLASTOMA; NEOPLASMS, RADIATION-INDUCED; PROTONS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SWEDEN;

EID: 28844476735     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860500355959     Document Type: Review

References (64)

1. Cancer Incidence in Sweden. Epidemiologiskt Centrum 2003; www.sos.se.
2. Gustavsson G, Langmark F, Pihkala U. Childhood Cancer in the Nordic Countries. Report on Epidemiologic and Therapeutic Results from Registries and Working Groups. NOPHO Annual Meeting Gothenburg May 1999.
3. Hakulinen T, Andersen A, Malker B, Pukkala E, Schou G, Tulinius H. Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries. Acta Pathol Microbiol Immunol Scand Suppl 1986;288:1-151.
4. Hjalmars U, Kulldorff M, Wahlqvist Y, Lannering B. Increased incidence rates but no space-time clustering of childhood astrocytoma in Sweden, 1973-1992: a population-based study of pediatric brain tumors. Cancer 1999;85:2077-90.
5. Adami HO, Glimelius B, Sparen P, Holmberg L, Krusemo UB, Ponten J. Trends in childhood and adolescent cancer survival in Sweden 1960 through 1984. Acta Oncol 1992;31:1-10.
6. Talbäck M, Stenbeck M, Rosén M, Glimelius B. Cancer survival in Sweden. Acta Oncol 2003;42:637-59.
7. Magnani C, Aareleid T, Viscomi S, Pastore G, Berrino R Variation in survival of children with central nervous system (CNS) malignancies diagnosed in Europe between 1978 and 1992: the EUROCARE study. Eur J Cancer 2001;37:711-21.
8. Moller TR, Garwicz S, Perfekt R, Barlow L, Winther JF, Glattre E, et al. Late mortality among five-year survivors of cancer in childhood and adolescence. Acta Oncol 2004;43:711-8.
9. Moller TR, Garwicz S, Barlow L, Falck Winther J, Glattre E, Olafsdottir G, et al. Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. J Clin Oncol 2001;19:3173-81.
10. Paterson R. The treatment of malignant disease by radium and x-rays being a practice of radiotherapy. London: Edward Arnold & Co; 1948.
11. Taylor RE. Cancer in children: radiotherapeutic approaches. Br Med Bull 1996;52:873-86.
12. Deacon J, Peckham MJ, Steel GG. The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol 1984;2:317-23.
13. Deutsch M. Medulloblastoma: staging and treatment outcome. Int J Radiat Oncol Biol Phys 1988;14:1103-7.
14. Gilbertson RJ. Medulloblastoma: signalling a change in treatment. Lancet Oncol 2004;5:209-18.
15. Packer RJ, Cogen P, Vezina G, Rorke LB. Medulloblastoma: clinical and biologic aspects. Neuro-oncol 1999;1:232-50.
16. Perthes G. ber den Einfluss der Roentgen strahlen auf epitheliale gewebe, insbesondere auf das Carcinmom. Archne für Klinische Chirurgie 1903;79:955-1000.
17. Desjardins AU. Osteogenic tumor: Growth injury of bone and muscular atrophy following therapeutic irradiation. Radiology 1930;14:296-308.
18. Stevens RH. Retardation of bone growth following roentgen irradiation of an extensive nevocarcinoma of the skin in a infant four month of age. Radiology 1935;25:538-54.
19. Probert JC, Parker BR. The effects of radiation therapy on bone growth. Radiology 1975;114:155-62.
20. Miralbell R, Bieri S, Mermillod B, Helg C, Sancho G, Pastoors B, et al. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease. J Clin Oncol 1996;14:579-85.
21. Paulino AC, Wen BC, Brown CK, Tannous R, Mayr NA, Zhen WK, et al. Late effects in children treated with radiation therapy for Wilms' tumor. Int J Radiat Oncol Biol Phys 2000;46:1239-46.
22. Adan L, Trivin C, Sainte-Rose C, Zucker JM, Hartmann O, Brauner R. GH deficiency caused by cranial irradiation during childhood: factors and markers in young adults. J Clin Endocrinol Metab 2001;86:5245-51.
23. Spoudeas HA, Charmandari E, Brook CG. Hypothalamopituitary-adrenal axis integrity after cranial irradiation for childhood posterior fossa tumours. Med Pediatr Oncol 2003;40:224-9.
24. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991;325:599-605.
25. Bhatia S, Ramsay NK, Bantle JP, Mertens A, Robison LL. Thyroid abnormalities after therapy for Hodgkin's disease in childhood. Oncologist 1996;1:62-7.
26. Constine LS, Schwartz RG, Savage DE, King V, Muhs A. Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin's disease. Int J Radiat Oncol Biol Phys 1997;39:897-906.
27. Jakacki RI, Goldwein JW, Larsen RL, Barber G, Silber JH. Cardiac dysfunction following spinal irradiation during childhood. J Clin Oncol 1993,11:1033-8.
28. Gurney JG, Kadan-Lottick NS, Packer RJ, Neglia JP, Sklar CA, Punyko JA, et al. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 2003;97:663-73.
29. Muller HL, Klinkhammer-Schalke M, Seelbach-Gobel B, Hartmann AA, Kuhl J. Gonadal function of young adults after therapy of malignancies during childhood or adolescence. Eur J Pediatr 1996;155:763-9.
30. Relander T, Cavallin-Ståhl E, Garwicz S, Olsson AM, Willen M. Gonadal and sexual function in men treated for childhood cancer. Med Pediatr Oncol 2000;35:52-63.
31. Meadows AT, Gordon J, Massari DJ, Littman P, Fergusson J, Moss K. Declines in IQ scores and cognitive dysfunctions in children with acute lymphocytic leukaemia treated with cranial irradiation. Lancet 1981;2:1015-8.
32. Jannoun L, Bloom HJ. Long-term psychological effects in children treated for intracranial tumors. Int J Radiat Oncol Biol Phys 1990;18:747-53.
33. Mulhern RK, Palmer SL. Neurocognitive late effects in pediatric cancer. Curr Probl Cancer 2003;27:177-97.
34. Lannering B, Marky I, Lundberg A, Olsson E. Long-term sequelae after pediatric brain tumors: their effect on disability and quality of life. Med Pediatr Oncol 1990;18:304-10.
35. McHaney V, Kovnar E, Meyer W, et al. Effects of radiation therapy and chemotherapy on hearing. In: Green DM, Dàngio GJ, editors. Late effects of treatment for childhood cancer, 1st ed. New York: Wiley Liss; 1992. p. 7-10.
36. Schell MJ, McHaney VA, Green AA, Kun LE, Hayes FA, Horowitz M, et al. Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. J Clin Oncol 1989;7:754-60.
37. Fukunaga-Johnson N, Sandler HM, Marsh R, Martel MK. The use of 3D conformal radiotherapy (3D CRT) to spare the cochlea in patients with medulloblastoma. Int J Radiat Oncol Biol Phys 1998;41:77-82.
38. Stavrou T, Bromley CM, Nicholson HS, Byrne J, Packer RJ, Goldstein AM, et al. Prognostic factors and secondary malignancies in childhood medulloblastoma. J Pediatr Hematol Oncol 2001;23:431-6.
39. Metayer C, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 2000;18:2435-43.
40. Guibout C, Adjadj E, Rubino C, Shamsaldin A, Grimaud E, Hawkins M, et al. Malignant breast tumors after radiotherapy for a first cancer during childhood. J Clin Oncol 2005;23:197-204.
41. Dores GM, Metayer C, Curtis RE, Lynch CF, Clarke EA, Glimelius B, et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 2002;20:3484-94.
42. Moppett J, Oakhill A, Duncan AW. Second malignancies in children: the usual suspects? Eur J Radiol 2001;38:235-48.
43. Travis L. Therapy-associated secondary solid cancer. Acta Oncol 2002;41:323-33.
44. Fossa SD. Long-term sequelae after cancer therapy - survivorship after treatment for testicular cancer. Acta Oncol 2004;43:134-41.
45. Dasu A, Toma-Dasu I, Olofsson J, Karlsson M. The use of risk estimation models for the induction of secondary cancers following radiotherapy. Acta Oncol 2005;44:339-47.
46. Kleinerman RA, Tucker MA, Tarone RE, Abramson DH, Seddon JM, Stovall M, et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol 2005;23:2272-9.
47. Benk V, Liebsch NJ, Munzenrider JE, Efird J, McManus P, Suit H. Base of skull and cervical spine chordomas in children treated by high-dose irradiation. Int J Radiat Oncol Biol Phys 1995;31:577-81.
48. Hug EB, Sweeney RA, Nurre PM, Holloway KC, Slater JD, Munzenrider JE. Proton radiotherapy in management of pediatric base of skull tumors. Int J Radiat Oncol Biol Phys 2002;52:1017-24.
49. Fuss M, Hug EB, Schaefer RA, Nevinny-Stickel M, Miller DW, Slater JM, et al. Proton radiation therapy (PRT) for pediatric optic pathway gliomas: comparison with 3D planned conventional photons and a standard photon technique. Int J Radiat Oncol Biol Phys 1999;45:1117-26.
50. Hug EB, Muenter MW, Archambeau JO, DeVries A, Liwnicz B, Loredo LN, et al. Conformal proton radiation therapy for pediatric low-grade astrocytomas. Strahlenther Onkol 2002;178:10-7.
51. Noel G, Habrand JL, Helfre S, Mammar H, Kalifa C, Ferrand R, et al. Proton beam therapy in the management of central nervous system tumors in childhood: the preliminary experience of the Centre de Protontherapie d'Orsay. Med Pediatr Oncol 2003;40:309-15.
52. Hug EB, Nevinny-Stickel M, Fuss M, Miller DW, Schaefer RA, Slater JD. Conformal proton radiation treatment for retroperitoneal neuroblastoma: introduction of a novel technique. Med Pediatr Oncol 2001;37:36-41.
53. Yuh GE, Loredo LN, Yonemoto LT, Bush DA, Shahnazi K, Preston W, et al. Reducing toxicity from craniospinal irradiation: using proton beams to treat medulloblastoma in young children. Cancer J 2004;10:386-90.
54. Wambersie A, Gregroire V, Brucher JM. Potential clinical gain of proton (and heavy ion) beams for brain tumors in children. Int J Radiat Oncol Biol Phys 1992;22:275-86.
55. Isacsson U, Hagberg H, Johansson KA, Montelius A, Jung B, Glimelius B. Potential advantages of protons over conventional radiation beams for paraspinal tumours. Radiother Oncol 1997;45:63-70.
56. Lin R, Hug EB, Schaefer RA, Miller DW, Slater JM, Slater JD. Conformal proton radiation therapy of the posterior fossa: a study comparing protons with three-dimensional planned photons in limiting dose to auditory structures. Int J Radiat Oncol Biol Phys 2000;48:1219-26.
57. Fuss M, Poljanc K, Miller DW, Archambeau JO, Slater JM, Slater JD, et al. Normal tissue complication probability (NTCP) calculations as a means to compare proton and photon plans and evaluation of clinical appropriateness of calculated values. Int J Cancer 2000;90:351-8.
58. Miralbell R, Lomax A, Cella L, Schneider U. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys 2002;54:824-9.
59. Krengli M, Hug EB, Adams JA, Smith AR, Tarbell NJ, Munzenrider JE. Proton radiation therapy for retinoblastoma: comparison of various intraocular tumor locations and beam arrangements. Int J Radiat Oncol Biol Phys 2005;61:583-93.
60. Yock TI, Tarbell NJ. Technology insight: proton beam radiotherapy for treatment in pediatric brain tumours. Review. Nature Clinical Practice Oncology 2004;1:97-103.
61. Gademann G, Wannenmacher M. Charged particle therapy to pediatric tumors of the retroperitoneal region: a possible indication. Int J Radiat Oncol Biol Phys 1992;22:375-81.
62. Möller T, Brorsson B, Ceberg J, Frodin JE, Lindholm C, Nylen U, et al. A propective survey of radiotherapy practice 2001 in Sweden. Acta Oncol 2003;42:387-410.
63. Lundkvist J, Ekman M, Rehn Ericsson S, Jönsson B, Glimelius B. Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma. Cancer 2005;103:793-801.
64. Taylor RE. Proton radiotherapy for paediatric tumours: potential areas for clinical research. Clin Oncol (R Coll Radiol) 2003;15:S32-6.